Continuity of care among patients newly initiated on second-generation oral or long-acting injectable antipsychotics during a schizophrenia-related inpatient stay

References

• National Institute of Mental Health. Schizophrenia. 2020. Available from: https://www.nimh.nih.gov/health/topics/schizophrenia
   Google Scholar
• Kahn RS, Sommer IE, Murray RM, et al. Schizophrenia. Nat Rev Dis Primers. 2015;1:15067. doi: 10.1038/nrdp.2015.67.
   PubMed Web of Science ®Google Scholar
• Evans DL, Foa EB, Gur RE, et al. Treating and preventing adolescent mental health disorders: what We know and what We don’t know. New York: Oxford University Press; 2017.
   Google Scholar
• Kessler RC, Birnbaum H, Demler O, et al. The prevalence and correlates of nonaffective psychosis in the national comorbidity survey replication (NCS-R). Biol Psychiatry. 2005;58(8):668–676. doi: 10.1016/j.biopsych.2005.04.034.
   PubMed Web of Science ®Google Scholar
• Wu EQ, Shi L, Birnbaum H, et al. Annual prevalence of diagnosed schizophrenia in the USA: a claims data analysis approach. Psychol Med. 2006;36(11):1535–1540. doi: 10.1017/S0033291706008191.
   PubMed Web of Science ®Google Scholar
• Desai PR, Lawson KA, Barner JC, et al. Estimating the direct and indirect costs for community-dwelling patients with schizophrenia. J Pharm Health Serv Res. 2013;4(4):187–194. doi: 10.1111/jphs.12027.
   Google Scholar
• Pilon D, Patel C, Lafeuille MH, et al. Prevalence, incidence and economic burden of schizophrenia among medicaid beneficiaries. Curr Med Res Opin. 2021;37(10):1811–1819. doi: 10.1080/03007995.2021.1954894.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Practice guideline for the treatment of patients with schizophrenia. 3rd ed. Washington (DC): APA. 2021. p. 1–312.
   Google Scholar
• Olfson M, Wall M, Wang S, et al. Short-term suicide risk after psychiatric hospital discharge. JAMA Psychiatry. 2016;73(11):1119–1126. doi: 10.1001/jamapsychiatry.2016.2035.
   PubMed Web of Science ®Google Scholar
• Qin P, Nordentoft M. Suicide risk in relation to psychiatric hospitalization: evidence based on longitudinal registers. Arch Gen Psychiatry. 2005;62(4):427–432. doi: 10.1001/archpsyc.62.4.427.
   PubMed Web of Science ®Google Scholar
• Velligan DI, Lam F, Ereshefsky L, et al. Psychopharmacology: perspectives on medication adherence and atypical antipsychotic medications. Psychiatr Serv. 2003;54(5):665–667. doi: 10.1176/appi.ps.54.5.665.
   PubMed Web of Science ®Google Scholar
• Lafeuille MH, Gravel J, Lefebvre P, et al. Patterns of relapse and associated cost burden in schizophrenia patients receiving atypical antipsychotics. J Med Econ. 2013;16(11):1290–1299. doi: 10.3111/13696998.2013.841705.
   PubMedGoogle Scholar
• Agency for Healthcare and Research Quality. Statistical brief #189 hospital readmissions involving psychiatric disorders 2012. Rockville (MD): AHRQ; 2015.
   Google Scholar
• Wani RJ, Kathe NJ, Klepser DG. Predictors of cost and incidence of 30-Day readmissions following hospitalizations for schizophrenia and psychotic disorders: a nationwide analysis. Qual Manag Health Care. 2019;28(3):130–138. doi: 10.1097/QMH.0000000000000223.
   PubMed Web of Science ®Google Scholar
• Agency for Healthcare and Research Quality. Statistical brief #172 conditions with the largest number of adult hospital readmissions by payer 2011. Rockville (MD): AHRQ; 2014.
   Google Scholar
• National Committee for Quality Assurance. HEDIS measures and technical resources. Washington (DC): NCQA; 2022 [cited 2022 Sep 27]. Available from: https://www.ncqa.org/hedis/measures/.
   Google Scholar
• Higashi K, Medic G, Littlewood KJ, et al. Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review. Ther Adv Psychopharmacol. 2013;3(4):200–218. doi: 10.1177/2045125312474019.
   PubMedGoogle Scholar
• Zhang W, Amos TB, Gutkin SW, et al. A systematic literature review of the clinical and health economic burden of schizophrenia in privately insured patients in the United States. Clinicoecon Outcomes Res. 2018;10:309–320. doi: 10.2147/CEOR.S156308.
   PubMed Web of Science ®Google Scholar
• Lin D, Thompson-Leduc P, Ghelerter I, et al. Real-world evidence of the clinical and economic impact of long-acting injectable versus oral antipsychotics among patients with schizophrenia in the United States: a systematic review and meta-analysis. CNS Drugs. 2021;35(5):469–481. doi: 10.1007/s40263-021-00815-y.
   PubMed Web of Science ®Google Scholar
• Pilon D, Tandon N, Lafeuille MH, et al. Treatment patterns, health care resource utilization, and spending in medicaid beneficiaries initiating second-generation long-acting injectable agents versus oral atypical antipsychotics. Clin Ther. 2017;39(10):1972–1985 e2. doi: 10.1016/j.clinthera.2017.08.008.
   PubMed Web of Science ®Google Scholar
• Marcus SC, Zummo J, Pettit AR, et al. Antipsychotic adherence and rehospitalization in schizophrenia patients receiving oral versus long-acting injectable antipsychotics following hospital discharge. J Manag Care Spec Pharm. 2015;21(9):754–768. doi: 10.18553/jmcp.2015.21.9.754.
   PubMed Web of Science ®Google Scholar
• Tyler N, Wright N, Waring J. Interventions to improve discharge from acute adult mental health inpatient care to the community: systematic review and narrative synthesis. BMC Health Serv Res. 2019;19(1):883. doi: 10.1186/s12913-019-4658-0.
   PubMed Web of Science ®Google Scholar
• HealthVerity, Inc. HealthVerity Marketplace. 2023 [cited 2023 Apr 3]. Available from: https://healthverity.com/solutions/healthverity-marketplace/
   Google Scholar
• US Department of Health and Human Services. 45 CFR 46: pre-2018 requirements. 2021 [cited 2021 Nov 10]. Available from: https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/index.html#46.101
   Google Scholar
• Austin PC. Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research. Commun Stat Simul Comput. 2009;38(6):1228–1234. doi: 10.1080/03610910902859574.
   Web of Science ®Google Scholar
• Patel C, Emond B, Morrison L, et al. Risk of subsequent relapses and corresponding healthcare costs among recently-relapsed medicaid patients with schizophrenia: a real-world retrospective cohort study. Curr Med Res Opin. 2021;37(4):665–674. doi: 10.1080/03007995.2021.1882977.
   PubMed Web of Science ®Google Scholar
• Dibonaventura M, Gabriel S, Dupclay L, et al. A patient perspective of the impact of medication side effects on adherence: results of a cross-sectional nationwide survey of patients with schizophrenia. BMC Psychiatry. 2012;12:20. doi: 10.1186/1471-244x-12-20.
   PubMed Web of Science ®Google Scholar
• Gilmer TP, Dolder CR, Lacro JP, et al. Adherence to treatment with antipsychotic medication and health care costs among medicaid beneficiaries with schizophrenia. Am J Psychiatry. 2004;161(4):692–699. doi: 10.1176/appi.ajp.161.4.692.
   PubMed Web of Science ®Google Scholar
• Haddad PM, Brain C, Scott J. Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies. Patient Relat Outcome Meas. 2014;5:43–62. doi: 10.2147/prom.S42735.
   PubMedGoogle Scholar
• Lang K, Meyers JL, Korn JR, et al. Medication adherence and hospitalization among patients with schizophrenia treated with antipsychotics. Psychiatr Serv. 2010;61(12):1239–1247. doi: 10.1176/ps.2010.61.12.1239.
   PubMed Web of Science ®Google Scholar
• Centers for Medicare and Medicaid Services. How to get prescription drug coverage. Baltimore (MD): CMS; 2022 [cited 2023 Jan 6]. Available from: https://www.medicare.gov/drug-coverage-part-d/how-to-get-prescription-drug-coverage
   Google Scholar
• Olfson M, Marcus SC, Doshi JA. Continuity of care after inpatient discharge of patients with schizophrenia in the medicaid program: a retrospective longitudinal cohort analysis. J Clin Psychiatry. 2010;71(7):831–838. doi: 10.4088/JCP.10m05969yel.
   PubMed Web of Science ®Google Scholar
• Lee SY, Kim KH, Kim T, et al. Outpatient follow-up visit after hospital discharge lowers risk of rehospitalization in patients with schizophrenia: a nationwide population-based study. Psychiatry Investig. 2015;12(4):425–433. doi: 10.4306/pi.2015.12.4.425.
   PubMed Web of Science ®Google Scholar
• Ngwa E, Winkfield D, Okunji P. Factors affecting the readmission rates and health care costs of patients hospitalized with schizophrenia: non-Adherence to treatment and increased relapses. ’JNBNA. 2020;31(2):67–70.
   Google Scholar
• Ortiz G. Predictors of 30-day postdischarge readmission to a multistate national sample of state psychiatric hospitals. J Healthc Qual. 2019;41(4):228–236. doi: 10.1097/JHQ.0000000000000162.
   PubMed Web of Science ®Google Scholar
• Burton R. Health policy brief: care transitions: health affairs. 2012 [cited 2022 Nov 28]. Available from: https://www.healthaffairs.org/do/10.1377/hpb20120913.327236/full/
   Google Scholar
• Macdonald A, Adamis D, Broadbent M, et al. Continuity of care and mortality in people with schizophrenia. BJPsych Open. 2021;7(4):e127. doi: 10.1192/bjo.2021.965.
   PubMed Web of Science ®Google Scholar
• Jabbarpour YM, Raney LE. Bridging transitions of care from hospital to community on the foundation of integrated and collaborative care. Focus. 2017;15(3):306–315. doi: 10.1176/appi.focus.20170017.
   PubMedGoogle Scholar
• Ruud T, Friis S. Continuity of care and therapeutic relationships as critical elements in acute psychiatric care. World Psychiatry. 2022;21(2):241–242. doi: 10.1002/wps.20966.
   PubMed Web of Science ®Google Scholar